June 10, 2022
An investor in the medical technology company Arrayit Corp. pleaded guilty to securities fraud in California federal court Thursday, admitting his role in a scheme to manipulate the prices of its stock through the spread of false and misleading information about the company, according to hearing minutes.
February 11, 2021
A California biotech company and its CEO have agreed to settle a U.S. Securities and Exchange Commission suit alleging that they lied to investors about the development of a blood test for the coronavirus.